Wells Fargo upgraded New York-headquartered Oscar Health (OSCR) from “Underweight” to “Equal Weight” on June 4, nearly doubling its price target from $11 to $20.
The upgrade was driven by analyst Stephen Baxter’s growing confidence in the trajectory of the health insurance exchange market in 2026, based on the firm’s analysis of statutory filings that showed enrollment and morbidity trending better than expected.